Immune Response to an Inactivated Vaccine of SARS-CoV-2 (CoronaVac) in an Indigenous Brazilian Population: A Cohort Study.

Laís Albuquerque de OliveiraIsa Rita Brito de MoraisMarcelo Dos Santos BarbosaSilvana Beutinger MarchioroLayla Oliveira Campos Leite MachadoMichele Ferreira MarquesTiago da Silva FerreiraGabriel Barroso de AlmeidaDyjaene de Oliveira BarbosaAlex José Leite TorresSimone Simionatto

Published in: Vaccines (2024)

To our best knowledge, this was the first comprehensive assessment of antibody and T-cell responses against CoronaVac vaccination in indigenous patients. Our findings showed that antibody response and T-cell immunity against SARS-CoV-2 were present in most patients following the vaccination schedule.

Keyphrases

sars cov
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
toll like receptor
inflammatory response